Logo image of RMED

RA MEDICAL SYSTEMS INC (RMED) Stock Analyst Earnings Estimates

NYSEARCA:RMED - NYSE Arca - US74933X3026 - Common Stock - Currency: USD

0.594  +0.05 (+10%)

After market: 0.5785 -0.02 (-2.61%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
RMED revenue by date.RMED revenue by date.
259K
-79.65%
22K
-91.51%
14K
-36.36%
1.969M
13,964.29%
8.813M
347.59%
21.287M
141.54%
EBITDA
YoY % growth
RMED ebitda by date.RMED ebitda by date.
-33.031M
35.05%
-27.701M
16.14%
-22.368M
19.25%
N/AN/AN/A
EBIT
YoY % growth
RMED ebit by date.RMED ebit by date.
-35.401M
32.71%
-29.266M
17.33%
-22.789M
22.13%
-72.726M
-219.13%
-3.305M
95.46%
4.121M
224.70%
Operating Margin
RMED operating margin by date.RMED operating margin by date.
-13,668.34%-133,027.27%-162,778.57%-3,693.55%-37.50%19.36%
EPS
YoY % growth
RMED eps by date.RMED eps by date.
-1,580.50
70.87%
N/A
87.69%
N/A-12.25-0.32
97.42%
0.30
193.55%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.31
97.72%
-0.23
94.62%
-0.17-0.13
99.46%
-0.12
60.26%
-0.07
69.57%
-0.01
94.12%
0.05
138.46%
0.02
116.67%
0.08
214.29%
0.14
1,500.00%
Revenue
Q2Q % growth
214.2K
4,184.00%
693.6K979.2K1.479M
1,640.00%
1.673M
681.05%
2.429M
250.20%
3.232M
230.07%
4.641M
213.79%
4.264M
154.87%
5.59M
130.14%
6.793M
110.18%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-1.846M
62.57%
-1.652M
61.04%
-1.408M
82.65%
-1.163M
88.82%
-1.193M
35.36%
-795.6K
51.85%
-163.2K
88.41%
724.2K
162.28%
285.6K
123.93%
1.081M
235.87%
2.03M
1,343.87%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth
-24.65
-82.59%
-0.35-24.30-6,987.00%
Q3 2022
Q2Q % growth
-4.36
92.42%
-8.163.8046.57%
Q2 2022
Q2Q % growth
-13.50
-954.69%
-8.16-5.34-65.44%
Q1 2022
Q2Q % growth
-13.50
-444.35%
-8.67-4.83-55.71%
Q4 2021
Q2Q % growth
-61.50
65.93%
-43.61-17.89-41.04%
Q3 2021
Q2Q % growth
-57.50
64.62%
-40.29-17.21-42.72%
Q2 2021
Q2Q % growth
-1.28
99.76%
-2.941.6656.43%
Q1 2021
Q2Q % growth
-2.48
99.65%
-3.000.5217.30%
Q4 2020
Q2Q % growth
-180.50
79.94%
-127.50-53.00-41.57%
Q3 2020
Q2Q % growth
-162.50
90.00%
-161.93-0.57-0.36%
Q2 2020
Q2Q % growth
-537.50
62.93%
-286.88-250.63-87.36%
Q1 2020
Q2Q % growth
-700.00
51.72%
-439.88-260.13-59.14%
Q4 2019
Q2Q % growth
-900.00 -1,470.50570.5038.80%
Q3 2019
Q2Q % growth
-1,625.00 -1,181.50-443.50-37.54%
Q2 2019
Q2Q % growth
-1,450.00 -1,245.25-204.75-16.44%
Q1 2019
Q2Q % growth
-1,450.00 -484.18-965.82-199.47%
RMED Yearly EPS VS EstimatesRMED Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth
85K
844.44%
71.4K13.6K19.05%
Q4 2022
Q2Q % growth

-100.00%
%
Q3 2022
Q2Q % growth

-100.00%
%
Q2 2022
Q2Q % growth
5K
-44.44%
5K%
Q1 2022
Q2Q % growth
9K
-99.19%
9K%
Q4 2021
Q2Q % growth
5K 357K-352K-98.60%
Q3 2021
Q2Q % growth
5K
-92.65%
714K-709K-99.30%
Q2 2021
Q2Q % growth
9K
-95.29%
1.242M-1.233M-99.28%
Q1 2021
Q2Q % growth
1.118M
-18.63%
1.001M117.211K11.71%
Q4 2020
Q2Q % growth

-100.00%
1.592M-1.592M-100.00%
Q3 2020
Q2Q % growth
68K
-96.44%
1.1M-1.032M-93.82%
Q2 2020
Q2Q % growth
191K
-91.13%
565.59K-374.59K-66.23%
Q1 2020
Q2Q % growth
1.374M
-21.40%
1.614M-240K-14.87%
Q4 2019
Q2Q % growth
1.39M 2.092M-702K-33.56%
Q3 2019
Q2Q % growth
1.908M 2.072M-164K-7.92%
Q2 2019
Q2Q % growth
2.153M 2.102M51K2.43%
Q1 2019
Q2Q % growth
1.748M 1.258M490K38.95%
RMED Yearly Revenue VS EstimatesRMED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% -1042.72%
Revenue0% 0% 0% 0.56%